Skip to main content
SpringerLink
Log in

Recent Progress in Sarcopenia Research: a Focus on Operationalizing a Definition of Sarcopenia

  • Epidemiology and Pathophysiology (F Cosman and D Shoback Section Editors)
  • Published:
Current Osteoporosis Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To discuss recent progress in sarcopenia research and to highlight controversies in the field particularly around reaching consensus on a definition of sarcopenia.

Recent Findings

Accordingly, this review begins with a discussion of the increasing awareness of this condition; briefly describes evolving definitions of sarcopenia; suggests a framework for consistent terminology for sarcopenia; discusses outstanding issues in the definition of sarcopenia; and reviews the association between sarcopenia and adverse outcome in older adults. In addition, the role of sarcopenia in other diseases is discussed.

Summary

The field of sarcopenia continues to hold considerable promise and work continues to resolve outstanding concerns in this field with a unifying consensus definition on the horizon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Drew L. Fighting the inevitability of ageing. Nature. 2018;555(7695):S15–S7 Narrative review of the history of sarcopenia research.

    Article  CAS  Google Scholar 

  2. Vellas B, Fielding RA, Bens C, Bernabei R, Cawthon PM, Cederholm T, et al. Implications of ICD-10 for sarcopenia clinical practice and clinical trials: report by the international conference on frailty and sarcopenia research task force. J Frailty Aging. 2018;7(1):2–9.

    CAS  PubMed  Google Scholar 

  3. Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, clinical modification (ICD-10-CM) code. J Am Med Dir Assoc. 2016;17(8):675–7.

    Article  Google Scholar 

  4. • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–23 The EWGSOP defintion is perhaps the most widely used operational defintion of sarcopenia.

    Article  Google Scholar 

  5. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56.

    Article  Google Scholar 

  6. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58.

    Article  Google Scholar 

  7. Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55(5):769–74.

    Article  Google Scholar 

  8. • Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–63 The landmark paper that proposed the first operational defitnion of sarcpenia. Despite potential methodological issues, this paper allowed for the first objective asessment of the impact of sarcopenia.

    Article  CAS  Google Scholar 

  9. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12(6):403–9.

    Article  Google Scholar 

  10. Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51(11):1602–9.

    Article  Google Scholar 

  11. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101.

    Article  Google Scholar 

  12. Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018;9(2):269–78. https://doi.org/10.1002/jcsm.12268.

    Article  Google Scholar 

  13. Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014;9(12):e113637.

    Article  Google Scholar 

  14. •• Dodds RM, Syddall HE, Cooper R, Kuh D, Cooper C, Sayer AA. Global variation in grip strength: a systematic review and meta-analysis of normative data. Age Ageing. 2016;45(2):209–16 Excellent descriptive paper that describes the epidemiology of grip strength, a major component of sarcopenia.

    Article  Google Scholar 

  15. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies. J Diabetes Metab Disord. 2017;16:21.

    Article  Google Scholar 

  16. Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez-Jimenez F, Bartels SJ. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy x-ray absorptiometry data from the national health and nutrition examination survey 1999–2004. J Am Geriatr Soc. 2013.

  17. • Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012;67(1):28–40 Review paper that summarizes the disconnent between strength and muscle size, summarizes the limited assocation between lean mass by DXA and functional decline.

    Article  Google Scholar 

  18. Clark BC, Manini TM. Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci. 2008;63(8):829–34.

    Article  Google Scholar 

  19. Studenski S. Bradypedia: is gait speed ready for clinical use? J Nutr Health Aging. 2009;13(10):878–80.

    Article  CAS  Google Scholar 

  20. •• Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. Jama. 2014;311(23):2387–96 Results of the LIFE trial demonstrated that structured activity prevents disability in older adults, representing the only proven intervention against physical disability currently available.

    Article  CAS  Google Scholar 

  21. •• Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiol Rev. 2013;35:51–65 Meta-analysis that demonstrates a robust association between adiposity, strength and function decline but no association between muscle size and functional decline.

    Article  Google Scholar 

  22. Cawthon PM, Blackwell TL, Cauley J, Kado DM, Barrett-Connor E, Lee CG, et al. Evaluation of the usefulness of consensus definitions of sarcopenia in older men: results from the Observational Osteoporotic Fractures in Men Cohort Study. J Am Geriatr Soc. 2015;63(11):2247–59.

    Article  Google Scholar 

  23. Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, et al. Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc. 2009;57(8):1411–9.

    Article  Google Scholar 

  24. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281(6):558–60.

    Article  CAS  Google Scholar 

  25. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85–94.

    Article  CAS  Google Scholar 

  26. Wong E, Stevenson C, Backholer K, Mannan H, Pasupathi K, Hodge A, et al. Adiposity measures as predictors of long-term physical disability. Ann Epidemiol. 2012;22(10):710–6.

    Article  Google Scholar 

  27. Guallar-Castillon P, Sagardui-Villamor J, Banegas JR, Graciani A, Fornes NS, Lopez Garcia E, et al. Waist circumference as a predictor of disability among older adults. Obesity. 2007;15(1):233–44.

    Article  Google Scholar 

  28. Flegal KM, Brownie C, Haas JD. The effects of exposure misclassification on estimates of relative risk. Am J Epidemiol. 1986;123(4):736–51.

    Article  CAS  Google Scholar 

  29. Heymsfield SB, Adamek M, Gonzalez MC, Jia G, Thomas DM. Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle. 2014;5(1):9–18.

    Article  Google Scholar 

  30. •• Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait speed and survival in older adults. Jama. 2011;305(1):50–8 Individualized participant-pooled data analysis that demonstrates the robust assocation between gait speed and mortality in older adults, highlighting the important of physical performance in assessing the risk of mortality in older persons.

    Article  CAS  Google Scholar 

  31. Perera S, Patel KV, Rosano C, Rubin SM, Satterfield S, Harris T, et al. Gait speed predicts incident disability: a pooled analysis. J Gerontol A Biol Sci Med Sci. 2016;71(1):63–71.

    Article  Google Scholar 

  32. Rantanen T. Muscle strength, disability and mortality. Scand J Med Sci Sports. 2003;13(1):3–8.

    Article  CAS  Google Scholar 

  33. Rantanen T, Avlund K, Suominen H, Schroll M, Frandin K, Pertti E. Muscle strength as a predictor of onset of ADL dependence in people aged 75 years. Aging Clin Exp Res. 2002;14(3 Suppl):10–5.

    PubMed  Google Scholar 

  34. Fragala MS, Alley DE, Shardell MD, Harris TB, McLean RR, Kiel DP, et al. Comparison of handgrip and leg extension strength in predicting slow gait speed in older adults. J Am Geriatr Soc. 2016;64(1):144–50.

    Article  Google Scholar 

  35. Alley DE, Shardell MD, Peters KW, McLean RR, Dam TT, Kenny AM, et al. Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A Biol Sci Med Sci. 2014;69(5):559–66.

    Article  Google Scholar 

  36. Duchowny KA, Peterson MD, Clarke PJ. Cut points for clinical muscle weakness among older Americans. Am J Prev Med. 2017;53(1):63–9.

    Article  Google Scholar 

  37. Cummings SR, Studenski S, Ferrucci L. A diagnosis of dismobility–giving mobility clinical visibility: a mobility working group recommendation. JAMA. 2014;311(20):2061–2.

    Article  CAS  Google Scholar 

  38. Liu P, Hao Q, Hai S, Wang H, Cao L, Dong B. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas. 2017;103:16–22.

    Article  Google Scholar 

  39. Chang SF, Lin PL. Systematic literature review and meta-analysis of the association of sarcopenia with mortality. Worldviews Evid-Based Nurs. 2016;13(2):153–62.

    Article  Google Scholar 

  40. Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548.

    Article  Google Scholar 

  41. Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290–8.

    Article  Google Scholar 

  42. Zhang H, Lin S, Gao T, Zhong F, Cai J, Sun Y, et al. Association between sarcopenia and metabolic syndrome in middle-aged and older non-obese adults: a systematic review and meta-analysis. Nutrients. 2018;10(3). https://doi.org/10.3390/nu10030364.

    Article  Google Scholar 

  43. Zhang Y, Hao Q, Ge M, Dong B. Association of sarcopenia and fractures in community-dwelling older adults: a systematic review and meta-analysis of cohort studies. Osteoporos Int. 2018;29(6):1253–62. https://doi.org/10.1007/s00198-018-4429-5.

    Article  CAS  Google Scholar 

  44. Chang KV, Hsu TH, Wu WT, Huang KC, Han DS. Association between sarcopenia and cognitive impairment: a systematic review and Meta-analysis. J Am Med Dir Assoc. 2016;17(12):1164.e7–1164.e15.

    Article  Google Scholar 

  45. Zhao Y, Zhang Y, Hao Q, Ge M, Dong B. Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis. Aging Clin Exp Res. 2018. https://doi.org/10.1007/s40520-018-0931-z.

  46. Lee WJ, Liu LK, Peng LN, Lin MH, Chen LK. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc. 2013;14(7):528.e1-7.

    Article  Google Scholar 

  47. Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med. 2009;169(22):2071–7.

    Article  Google Scholar 

  48. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35.

    Article  Google Scholar 

  49. Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58–67.

    Article  Google Scholar 

  50. Kahn J, Wagner D, Homfeld N, Müller H, Kniepeiss D, Schemmer P. Both sarcopenia and frailty determine suitability of patients for liver transplantation - a systematic review and meta-analysis of the literature. Clin Transplant. 2018;32(4):e13226. https://doi.org/10.1111/ctr.13226.

    Article  Google Scholar 

  51. van Vugt JL, Levolger S, de Bruin RW, van Rosmalen J, Metselaar HJ, IJzermans JN. Systematic review and meta-analysis of the impact of computed tomography-assessed skeletal muscle mass on outcome in patients awaiting or undergoing liver transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2016;16(8):2277–92.

    Article  Google Scholar 

  52. Simonsen C, de Heer P, Bjerre ED, Suetta C, Hojman P, Pedersen BK, et al. Sarcopenia and postoperative complication risk in gastrointestinal surgical oncology: a meta-analysis. Ann Surg. 2018;268(1):58–69. https://doi.org/10.1097/SLA.0000000000002679.

    Article  Google Scholar 

  53. Zhang G, Meng S, Li R, Ye J, Zhao L. Clinical significance of sarcopenia in the treatment of patients with primary hepatic malignancies, a systematic review and meta-analysis. Oncotarget. 2017;8(60):102474–85.

    PubMed  PubMed Central  Google Scholar 

  54. Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. PLoS One. 2017;12(10):e0186990.

    Article  Google Scholar 

  55. Shen Y, Hao Q, Zhou J, Dong B. The impact of frailty and sarcopenia on postoperative outcomes in older patients undergoing gastrectomy surgery: a systematic review and meta-analysis. BMC Geriatr. 2017;17(1):188.

    Article  Google Scholar 

  56. Jones K, Gordon-Weeks A, Coleman C, Silva M. Radiologically determined sarcopenia predicts morbidity and mortality following abdominal surgery: a systematic review and meta-analysis. World J Surg. 2017;41(9):2266–79.

    Article  Google Scholar 

  57. Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, et al. Clustering of strength, physical function, muscle, and adiposity characteristics and risk of disability in older adults. J Am Geriatr Soc. 2011;59(5):781–7.

    Article  Google Scholar 

  58. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61(10):1059–64.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. San Francisco Coordinating Center, 550 16th Street, 2nd Floor, Box #0560, San Francisco, CA, 94143, USA

    Peggy M. Cawthon

Authors
  1. Peggy M. Cawthon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peggy M. Cawthon.

Ethics declarations

Conflict of Interest

Peggy Cawthon reports non-financial support from GSK outside the submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Epidemiology and Pathophysiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cawthon, P.M. Recent Progress in Sarcopenia Research: a Focus on Operationalizing a Definition of Sarcopenia. Curr Osteoporos Rep 16, 730–737 (2018). https://doi.org/10.1007/s11914-018-0484-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11914-018-0484-2

Keywords

Search

Navigation